Both in Pharmaceuticals
Amneal Pharmaceuticals vs Oruka Therapeutics
Over the past year AMRX returned +80.5% and ORKA returned +280.1%; their daily moves had a correlation of 0.13.
AMRX +80.5% ORKA +280.1%Growth of $1, one year, split-adjusted
| Metric | AMRX | ORKA |
|---|---|---|
| Price | $20.21 | $99.55 |
| Market cap | $7.04B | $6.59B |
| Today | −1.13% | +4.32% |
| 1 month | −0.7% | +18.0% |
| 6 months | +50.7% | +44.4% |
| Year to date | +60.4% | +228.4% |
| 1 year | +86.8% | +253.4% |
| Revenue growth (YoY) | +9.9% | — |
| Gross margin | 42.0% | — |
| Net margin | 7.2% | — |
| P/E (TTM) | 44.7× | — |
| Price / sales | 2.3× | — |
| Net cash | -$2.54B | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 39.1% | 51.7% |
| Short % of float | 8.2% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).